Sign In
Buy BHC
$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
Steven Cohen Expands Health Care Holdings With Tricida
12:57pm, Friday, 26'th Mar 2021
After previously exiting a position in the fourth quarter of 2020, Point72 Asset Management leader Steven Cohen (Trades, Portfolio) disclosed a new 5.03% stake in Tricida Inc. (NASDAQ:TCDA) earlier th
Why Do These Value Investors Love Resolute Forest Products?
12:55pm, Friday, 26'th Mar 2021
Francis Chou (Trades, Portfolio)'s Chou Associates and Prem Watsa (Trades, Portfolio)'s Fairfax Financial both own a significant stake in Resolute Forest Products (NYSE:RFP).
Why Did BofA Downgrade Bausch Health?
11:39am, Wednesday, 24'th Mar 2021
There are challenges to value creation in the proposed separation of Bausch Health Companies Inc's (NYSE: BHC) Bausch and Lomb (B&L) unit and RemainCo, which will be pharma-focused, according to BofA
Larry Robbins' Firm Buys Into HighCape Capital Acquisition
03:37pm, Tuesday, 16'th Mar 2021
Larry Robbins ( Trades , Portfolio )'s firm has revealed a new buy into HighCape Capital Acquisition Corp. (NASDAQ:CAPA) according to GuruFocus' Real-Time Picks, a Premium feature.
Bausch Health Companies Inc. (BHC) CEO Joe Papa Presents at Barclays Global Healthcare Conference (Transcript)
08:04pm, Tuesday, 09'th Mar 2021
Bausch Health Companies Inc. (BHC) CEO Joe Papa Presents at Barclays Global Healthcare Conference (Transcript)
What Happens to PSTH Stock After Mega-Deal Announced
12:33pm, Thursday, 04'th Mar 2021
Markets expect a big payout when Pershing finally puts its money to good use through a monster-sized acquisition. The post What Happens to PSTH Stock After Mega-Deal Announced appeared first on Invest
Bausch Health Companies Inc. (BHC) Management Presents at J.P. Morgan Global High Yield & Leveraged Finance Conference (Transcript)
07:55pm, Wednesday, 03'rd Mar 2021
Bausch Health Companies Inc. (BHC) Management Presents at J.P. Morgan Global High Yield & Leveraged Finance Conference (Transcript)
Bausch Health's (BHC) CEO Joe Papa Presents at Cowen 41st Annual Health Care Conference (Transcript)
02:06pm, Monday, 01'st Mar 2021
Bausch Health's (BHC) CEO Joe Papa Presents at Cowen 41st Annual Health Care Conference (Transcript)
The Top New Buys of Larry Robbins' Firm
03:14pm, Friday, 26'th Feb 2021
Glenview Capital Management recently disclosed its portfolio updates for the fourth quarter of 2020, which ended on Dec. 31.
Should You Book Profits In Bausch Health Companies Stock After A Solid 2x Rally?
10:20am, Friday, 26'th Feb 2021
After a solid 2.4x rise from its March 2020 lows, at the current price of $31 per share, Bausch Health Companies' stock, best known for its contact lenses and branded generic drugs, appears to be full
Bausch's (BHC) Q4 Earnings and Revenues Surpass Estimates
01:40pm, Thursday, 25'th Feb 2021
Bausch (BHC) reports better-than-expected results for the fourth quarter as the business shows recovery signs from the COVID-19 pandemic.
Bausch Health Companies Inc. (BHC) CEO Joe Papa on Q4 2020 Results - Earnings Call Transcript
02:33pm, Wednesday, 24'th Feb 2021
Bausch Health Companies Inc. (BHC) CEO Joe Papa on Q4 2020 Results - Earnings Call Transcript
Bausch Health Adds 2 Directors Chosen By Carl Icahn: What Investors Need To Know
01:50pm, Wednesday, 24'th Feb 2021
Bausch Health Companies Inc (NYSE: BHC) is expanding its board of directors to accommodate two designees from activist investor Carl Icahn's Icahn Group, which owns 7.83% of the company's outstanding
Bausch Health (BHC) Q4 Earnings Beat Estimates
10:37am, Wednesday, 24'th Feb 2021
Bausch (BHC) delivered earnings and revenue surprises of 19.82% and -0.23%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Bausch Health Q4 Earnings
07:48am, Wednesday, 24'th Feb 2021
Shares of Bausch Health Cos (NYSE:BHC) decreased 0.3% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 18.75% year over year to $1.33, which
